
HIV breakthrough faces critical funding cuts
A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten to undermine years of scientific progress. Lenacapavir, an
A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten to undermine years of scientific progress. Lenacapavir, an